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A B S T R A C T
Objective: To investigate cancer patients’ understanding of graphical presentations of longitudinal EORTC
QLQ-C30 scores.
Methods: We conducted semi-structured interviews with brain tumour patients participating in routine
patient-reported outcome (PRO) monitoring. We assessed understanding of longitudinal quality of life
(QOL) proﬁles, presented as bar charts objectively and with self-ratings. In addition, patients’ opinions on
congruency of the QOL scores with their self-perceived health status were evaluated.
Results: We recruited 40 brain tumour patients (57.5% female; mean age 52.7, SD 13.7). In total, 90% of
patients rated the graphs as easy to understand. Accordingly, almost all questions on assessing
understanding objectively were answered correctly by at least 80% of the patients. More than 95%
indicated that the displayed QOL scores matched their personal perception of symptom burden and
functional health in the observed period.
Conclusion: Patients are able to understand their QOL results when presented graphically and are able to
interpret important changes. Displayed QOL scores obtained with the EORTC QLQ-C30 are consistent
with the patients’ personal perception of physical and emotional functioning, pain and fatigue.
Practice implications: Knowledge about patients’ understanding of graphically displayed QOL results
contributes to creation of optimal evidence-based feedback on the patients’ present QOL and its
trajectory.
ã 2016 The Author(s). Published by Elsevier Ireland Ltd. This is an open access article under the CC BY-NC-
ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Patient-reported outcomes (PROs) reﬂect a patient’s individual
perspective on symptom experience, functional health, individual
resources, and treatment beneﬁt. Collecting such data is expected
to provide several beneﬁts. In a clinical setting it has been shown to
improve patient-clinician communication by identifying impor-
tant symptoms and issues before a consultation and to allow
patients’ information needs to be addressed more comprehen-
sively [1–5]. This use of PROs is also associated with fewer hospital* Corresponding author.
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nd/4.0/).visits [6,7]. While there is currently only scant evidence for a direct
impact on the patient’s quality of life (QOL) [1,3,4,6], the routine
assessment of PROs is on the rise and is the focus of substantial
research efforts [4,8–11].
Electronic PRO (ePRO) assessment systems have been devel-
oped to reduce time and staff requirements associated with having
patients complete PRO questionnaires [5,10]. ePRO systems
facilitate questionnaire completion and allow immediate presen-
tation of patient-reported information to clinicians. Efﬁcient PRO
data collection infrastructure not only allows timely reporting to
the treatment team, but also enables data collection via web-based
patient portals and automatic data storage in electronic medical
records. To facilitate interpretation of data, PRO results can be
displayed as simple graphs of cross-sectional or longitudinal data,
a presentation style that is generally preferred by patients and
professionals [5,11–13].
However, to date there is still a lack of research on the optimal
graphical presentation of multidimensional PRO data. Very few article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-
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the graph itself (e.g. bar or line charts, use of colour), or the
complexity of the displayed data (i.e. the amount of information
included in the graph). Such information is essential to support
successful implementation of ePRO systems in clinical practice and
in web-based patient portals. A recent mixed-methods study on
graphical presentation styles found that patients and clinicians
prefer line graphs for group-level data and individual-level data
formats but ﬁnd statistical details like conﬁdence intervals, norms,
and p values confusing [8]. Another study on user-centred design
of QOL reports showed that cancer patients preferred bar charts
over line charts or pictograms [15]. The latter ﬁnding was
conﬁrmed by Kuijpers et al. [12] who additionally compared
patients’ perceived understanding of the QOL results with
objectively measured understanding assessed through speciﬁc
exam-like questions. In their large cross-cultural study, Kuijpers
et al. found a rather low degree of objectively measured
understanding, with percentages of correct answers ranging from
42.8% to 76.7%, depending on question type and QOL domain. The
authors highlighted the substantial difference between self-rated
and objectively measured understanding of the graphs, and
hypothesised that patients may understand their own QOL results
better than hypothetical patient data. To the best of our knowledge,
no study has investigated graphical presentation styles by
presenting patients with their own previously collected QOL
results in a longitudinal format.
Therefore, we conducted a mixed-method study aimed at
exploring patients’ understanding of graphical presentation of
their own QOL scores. In addition, we assessed the consistency of
the presented data with patients’ perceived health status.Fig. 1. Graphical presentation of PRO 2. Methods
2.1. Sample and setting
We recruited patients treated at the Department of Neurology
and Neurosurgery at the Medical University of Innsbruck (Austria).
This patient group and department were selected for the study
because routine QOL monitoring has been in place since 2005 [16]
using the ePRO software CHES [17]. This allowed us to show
patients their own previously collected QOL data. Before this study
the QOL data has been used for research purposes and has been
provided to the treatment team, who occasionally discussed QOL
results with patients. Prior to this study patients themselves have
not been provided direct access to their QOL results.
We consecutively recruited in- and outpatients for our study
according to the following criteria:
 any brain tumour diagnosis
 any treatment type
 age between 18 and 80
 no obvious cognitive impairments
 previous participation in QOL monitoring
Ethical approval of the study was obtained from the institu-
tional ethics committee [AN2014-0012].
2.2. Graphical presentation style
We used bar charts as previous studies indicate that they are
generally preferred and well understood by most patients [12,14].results as shown to the patients.
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assessment time points, with each point represented by a bar.
Time (assessment date) is given on the x-axis and questionnaire
scores on the y-axis. We presented 2 functional and 2 symptom
scales of the 15 QLQ-C30 domains that represent important areas
inﬂuenced by disease and treatment and have also been used in a
previous study [12]: Physical Functioning, Emotional Functioning,
Pain and Fatigue. The use of functional and symptom scales
allowed us to evaluate patients’ understanding of different scale
directions depending on whether a symptom or a functional
impairment is measured. Values below/above a predeﬁned
threshold for clinical importance were given as green (clinically
unimportant) or red (clinically important) bars. Thresholds for
clinical importance were distribution-based: scores in the range of
the lowest decile of the reference population (brain tumour
patients monitored at the department) were considered clinically
important (Fig. 1).
2.3. Procedure
In our mixed methods study we collected not only quantitative
patient ratings and percentages of correct answers, but also
assessed patients’ understanding of the graphical presentations
qualitatively within an interview.
The research assistant identiﬁed eligible patients in the medical
records and approached them for participation in the study. If
patients met the inclusion criteria, the research assistant informed
them about the study purpose and asked for written informed
consent. The research assistant then collected sociodemographic
data and clinical data not available from the medical records from
the patients. In a next step, patients completed the EORTC QLQ-C30
themselves on a tablet PC. The QLQ-C30 is an internationally
validated 30-item questionnaire assessing cancer-speciﬁc QOL
[18]. This widely used questionnaire comprises ﬁve functional
scales (Physical, Social, Role, Cognitive, and Emotional Function-
ing), nine symptom scales (fatigue, nausea/vomiting, pain,
dyspnoea, sleep disturbances, appetite loss, constipation, diar-
rhoea and ﬁnancial impact), and a global QOL scale. Each linear
converted scale score ranges from 0 to 100. High scores for
functional scales and for the global health status/QOL indicate
better functioning, whilst high scores for symptom scales
represent a higher level of symptom burden.
In a following step the research assistant interviewed the
patient on the comprehensibility of an introduction text, on his/her
understanding of the graphical result presentations and the
congruency of the QOL presentations with the patient’s own
perception. In detail, the interview comprised the following parts:
1 Presentation and evaluation of the introduction text:
After patients completed the EORTC QLQ-C30, the research
assistant presented a written introduction to familiarize the
patient with the concept of QOL and the way individual results of
the questionnaire can be presented as bar charts. This short
introduction also included information on the scoring of the
questionnaire and the meaning of higher and lower values (e.g.
“the chart presenting your pain level shows how strong your pain
was on the speciﬁc dates [ . . . ] In this case, scores between 0 and
100 mean that the higher your score, the stronger your pain or
fatigue at the speciﬁc dates”). The introduction text also explained
the meaning of the colour-coding: red for clinically important
problems and green for no (clinically important) problems.
Afterwards, the research assistant asked the patients to rate the
comprehensibility of the instruction text on a 4-point Likert scale
from very simple to very difﬁcult to understand.2 Qualitative interview on how patients interpret the graphical
result presentation:
We asked patients to report any information they were able to
extract from the presented bar charts. This was done separately for
each of the four domains shown.
3 Objective assessment of patients’ understanding:
We objectively assessed patients’ understanding of the QOL
results with exam-like questions about the meaning of the colour-
coding used to highlight clinically important problems and about
change. Questions on change asked about change over all time
points shown. In case of more than two assessments in total the
research assistant also asked about change between two speciﬁc
time points (between ﬁrst and last assessment as well as between
the two latest assessments). Hence, patients were asked if their
health status got better, worsened, was ﬂuctuating or did not
change at all. Understanding of the colour-coding was assessed by
asking the patient to identify clinically important problems on
each of the domains. The research assistant then classiﬁed each
patient answer as either right or wrong.
4 Congruency rating of graphical QOL outcomes with the
perceived health status:
Patients were asked whether the displayed questionnaire
results matched their personal perception of symptoms and
functional health during the period displayed. Patients could
answer on a 4-point Likert scale from “Not at all” to “Very much”.
5 Ease of interpretation rating of the QOL presentations:
Finally, the research assistant asked the patients to rate in
general how difﬁcult they found it to interpret the graphical QOL
result presentation (5-point Likert scale from “Very easy” to “Very
difﬁcult”).
2.4. Data analysis
Sample characteristics are given as means, standard deviations
and frequencies.
Results for questions on self-rated and objectively measured
understanding as well as on congruency of shown results with
patients’ perceptions are reported as absolute and relative
frequencies. Interview data were categorised with the help of
the software NVivo11 Starter using a category system that was
developed independently by two reviewers based on the interview
data and then harmonised in a consensus discussion. Categorisa-
tions of patients’ comments were also done independently by two
reviewers and then harmonised. Inter-rater reliability is given as
the percentage of categorisations with absolute agreement.
3. Results
3.1. Patient characteristics
We consecutively recruited 40 brain tumour patients partici-
pating in the on-going QOL monitoring at the neuro-oncological
outpatient and inpatient units of the Medical University of
Innsbruck. The longitudinal QOL assessments covered an average
period of 25.8 months (range: 1–90 months). For 31 patients
(77.5%) three or more QOL assessments were available. Mean
patient age was 52.7 years (SD 13.7) and 57.5% were female. Most
patients had an advanced disease, with 66.7% suffering from a
WHO stage III or IV disease. At the time of the assessment, 87.2% of
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are given in Table 1.
3.2. Objectively assessed understanding of the graphical presentations
Table 2 shows the proportion of correct answers for the
questions objectively assessing patients’ understanding of the
displayed bar charts. Nine patients had QOL data from just two
assessment time points; therefore, only one type of change (overall
change) was assessed. The percentage of correct answers for
questions about overall change was between 74.4% (fatigue) and
90.0% (emotional functioning). For change between two speciﬁc
time points, objectively assessed understanding was better:
accuracy was 87.1% for physical functioning, 93.5% for emotional
functioning, 96.8% for pain, and 90.3% for fatigue. For questions
related to changes between the ﬁrst and the last assessment,
answers were quite similar and mostly correct, with scores
between 80.6% and 93.5%.
The question on the meaning of colour-coding to highlight
clinically important problems was answered correctly by 100% of
the patients for the domains of physical function and pain, and by
92.5% for emotional function and fatigue.
3.3. Self-rated comprehensibility of the graphical presentations and
explanations
Most of the patients reported that the display of their personal
health status over all assessment time points and for the last
assessment matched their personal perception quite a bit or very
much (95.0% and 97.5%, respectively).
With regard to the self-rated comprehensibility of the
introduction texts (Table 3), 92.5% of the patients found the
explanations of the QOL terms “Very easy” or “Rather easy” to
understand. The instructions for the graphs, as well as the graphs
themselves, were rated as “very easy” or “rather easy” to
understand by 90% and 100%, respectively.Table 1
Patient characteristics (N = 40).
Age Mean (SD) 52.68 (13.73)
Range 2983
Sex Female 57.5%
Male 42.5%
Family status Single 25.0%
Married, not living together 5.0%
Married, living together 60.0%
Divorced 10.0%
Education Compulsory or less 10.0%
Vocational education 35.0%
Higher education 30.0%
University or similar 25.0%
Employment status Retired 70.0%
Full-time job 10.0%
Part-time job 5.0%
Homemaker 2.5%
Sick leave 7.5%
Other 5.0%
UICC stage (n = 24) I 4.2%
II 29.2%
III 41.7%
IV 25.0%
Treatment status (n = 39) On treatment 87.2%
Off treatment 12.8%3.4. Examples of patients’ comments in six categories
The semi-structured interviews resulted in 37 patients’
providing 191 comments on the graphical presentation of the
QOL results and related topics. Absolute agreement between
reviewers concerning categorisation of comments was 94.2%. The
harmonised category system comprised the following ﬁve topics:
1) Graphical presentation style (28 comments from 22 patients)
Comments on the graphical presentation style were mainly
positive (e.g. “I am pleasantly surprised; the graphs are easy”). Only
three patients reported problems interpreting a value of zero (e.g.
“Are the values too small to be displayed?”) Five patients with
small changes over time reported difﬁculty detecting a difference
in the heights of the bars (e.g. “The heights of the bars are a little
hard to read”). Other issues were problems with the colour-coding
(n = 2), the meaning of the values, which were mistaken for
percentages (n = 2) and the terms better/worse or more/less used
to indicate scale direction (n = 4).
2) Scale direction (11 comments from 6 patients)
Four patients commented that the inverse scale direction of
functioning and symptom scales is confusing (e.g. “First I thought
my health status had improved, because the green bar is higher
than before; and a green bar is a positive signal, but the graph is
displaying increased fatigue”). Two of these patients suggested
unifying the directionality of the scales. In contrast, two other
patients explicitly noted that the scale directions were easy to
understand.
3) Agreement of QOL results and perceived QOL (35 comments
from 20 patients)
While 10 patients claimed their symptoms were more intense
than indicated by the graphs, the other 10 evaluated the graphs as
precisely representing their health status during the previous
assessments (e.g. “They match 100%, because they just display my
personal information”).
4) Explanations for QOL results (47 comments from 21 patients)
About half of the patients (n = 21) spontaneously provided
explanations for their QOL scores, e.g. referring to the impact of
weather conditions (n = 4), cancer treatment (n = 7), or comorbidity
burden (n = 4). Some patients argued that things were going better
since they had developed a more positive attitude (n = 5) or had
accepted their disease (n = 4): (e.g. “I accepted the disease more
than before; that’s why it got better”).
5) General comments on QOL assessment and data (14 comments
from 9 patients)
Two patients emphasised the importance of routine monitoring
during treatment, while ﬁve patients expressed scepticism
regarding the ability of the graphs to capture the subjective/
personal perception of the personal QOL-status (e.g. “a computer
can’t reﬂect emotions”).
4. Discussion and conclusion
4.1. Discussion
In this study, we report on patients’ understanding of their own
QLQ scores presented as bar charts. Patients’ self-rated and
Table 2
Objectively assessed understanding.
Change over
all assessments
Problem according to graphs Change between 2 (last) assessments Change between 1 st and last assessment
right wrong right wrong right wrong right wrong
(N = 40)a (N = 40) (N = 31) (N = 31)
Physical functioning 32 (80.0) 8 (20.0) 40 (100) 0.0 27 (87.1) 4 (12.9) 28 (90.3) 3 (9.7)
Emotional functioning 36 (90.0) 4 (10.0) 37 (92.5) 3 (7.5) 29 (93.5) 2 (6.5) 29 (93.5) 2 (6.5)
Pain 32 (80.0) 8 (20.0) 40 (100) 0.0 30 (96.8) 1 (3.2) 28 (90.3) 3 (9.7)
Fatigue 29 (74.4) 10 (25.6) 37 (92.5) 3 (7.5) 28 (90.3) 3 (9.7) 25 (80.6) 6 (19.4)
a Fatigue N = 39.
Table 3
Comprehensibility of the QOL introductions texts, and of the graphs (N = 40).
Instruction QOL Instruction Graphs Graphs
very easy 24 (60.0) 24 (60.0) 18 (45.0)
rather easy 13 (32.5) 16 (40.0) 18 (45.0)
rather difﬁcult 2 (5.0) 0.0 4 (10.0)
very difﬁcult 1 (2.5) 0.0 0.0
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styles were both high. All questions objectively assessing
understanding were answered correctly by at least 80% of the
patients (with the exception of two questions with 74% accuracy).
In line with these results, 90% of the patients reported that the
graphs were “very easy” or “rather easy” to understand. The vast
majority of the patients (95%) said that the displayed symptom
and functioning trajectories matched their personal perceptions
“quite a bit” or “very much.” However, during the interview we also
identiﬁed difﬁculties with correct interpretation of the graphical
presentations. These involved the different directionality of the
symptom and functioning scales. Relative to reports from a recent
study by Kuijpers et al. [12], we found smaller discrepancies
between patients’ self-rated and objectively assessed understand-
ing of the graphical presentations. This may be due to the fact that
we objectively assessed understanding in a naturalistic setting,
presenting patients with their own QLQ-C30 scores from our on-
going routine QOL monitoring instead of hypothetical QOL data.
Compared with previous studies on group- and patient-level data,
which have accuracy rates between 64% and 98%, our ﬁndings on
objectively assessed understanding are in the upper end of that
range [11,15,19,20].
One limitation of our study is that we only evaluated one
graphical presentation style (coloured bar charts). However, the
selection was based on previous studies that highlighted patients’
preference for bar charts [12,15]. A further limitation is that we could
only include patients with brain tumours because we had to rely on a
department where routine QOL monitoring has been in place for
sufﬁcient time to allow presentation of patients’ own longitudinal
results. Therefore, we assessed a sample that might be more
impaired cognitively than would a mixed sample of cancer patients.
Taking this into account, our results might actually underestimate
the comprehensibility of the graphical presentations.
Based on the routine monitoring protocol at the Medical
University Innsbruck we used the 10th/90th percentile, because
scores exceeding these cut-offs are considered to be of particular
clinical relevance [16]. Compared with a recent study on thresh-
olds for clinically important problems [21] our thresholds were
considerably lower for functional scales and higher for symptom
scales, thereby displaying higher speciﬁcity but lower sensitivity.
Especially for symptom burden, patients might consider problems
clinically important at a lower level than our thresholds suggest.This means that comprehensibility of graphical presentations also
depends on the choice of meaningful thresholds for clinical
importance. For certain QOL trajectories it was hard to decide for
patients whether scores had changed or not. The reason was that
small changes between time points were considered irrelevant by
patients; therefore they rated the scores as (more or less) the same.
However, small differences in assessment scores should not be
overvalued, as such changes may be smaller than a minimally
important difference for the individual patient. Whereas our
colour-coding helped patients with interpretation of absolute
scores, we did not highlight clinically important changes, making
that aspect more difﬁcult to understand.
4.2. Conclusion
Patients are able to understand their QOL results when
presented graphically and interpret absolute scores and changes
over time Patients consider the QOL trajectories to adequately
match their own perceptions of their health status. If using
questionnaires such as the QLQ-C30 with different scale directions
for different subscales, provision of detailed information on the
meaning of high and low values is essential.
4.3. Practice implications
The ﬁndings from other published studies on this topic provide
important information to support the successful implementation
of QOL monitoring in daily clinical practice. Such knowledge
contributes to creation of optimal graphical presentations for QOL
results and identiﬁcation of issues requiring more detailed
explanation in patient information materials. We found that
patients were able to understand longitudinal data, which is
beneﬁcial, considering that previous studies have demonstrated
the importance of repeated assessments. Making QOL results
understandable for patients is likely to motivate them to
participate in routine QOL assessments, allows sharing informa-
tion used for medical decision making and contributes to patient
empowerment in general.
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